Magnetar Financial’s ResMed RMD Stock Holding History

Magnetar Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,805	Closed	-$1.45M	–	523
2023 Q3	$1.45M	Sell	9,805 -4,592	-32%	-$830K	0.04%	212
2023 Q2	$3.15M	Buy	14,397 +7,671	+114%	+$1.71M	0.07%	151
2023 Q1	$1.47M	Sell	6,726 -6,614	-50%	-$1.43M	0.03%	335
2022 Q4	$2.78M	Buy	+13,340	New	+$2.93M	0.05%	339
2022 Q1	–	Sell	-3,383	Closed	-$881K	–	1502
2021 Q4	$881K	Buy	+3,383	New	+$878K	0.01%	835
2021 Q2	–	Sell	-19,583	Closed	-$3.8M	–	1351
2021 Q1	$3.8M	Buy	+19,583	New	+$3.93M	0.04%	419
2017 Q4	–	Sell	-19,376	Closed	-$1.49M	–	859
2017 Q3	$1.49M	Buy	+19,376	New	+$1.48M	0.03%	185
2017 Q2	–	Sell	-15,595	Closed	-$1.12M	–	938
2017 Q1	$1.12M	Buy	+15,595	New	+$1.08M	0.02%	274
2016 Q4	–	Sell	-44,399	Closed	-$2.88M	–	315
2016 Q3	$2.88M	Buy	+44,399	New	+$2.96M	0.04%	139

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Magnetar Financial's RMD Position: Q4 2023 in Review

Magnetar Financial sold out of ResMed (RMD) in Q4 2023, closing a stake of 9,805 shares — an estimated $1.45M sold.

Magnetar Financial first reported a position in RMD in Q3 2016 and held it in 9 quarters. The position peaked at $3.8M in Q1 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Magnetar Financial reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Magnetar Financial sold 9,805 ResMed shares in Q4 2023, an estimated $1.45M.
Magnetar Financial first reported a position in ResMed in Q3 2016 and held it in 9 quarters.
Magnetar Financial's ResMed position peaked at $3.8M in Q1 2021.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Magnetar Financial's 13F filing for Q4 2023, filed 13 Feb 2024.